Transitioning Financial Responsibility for Health Programs from External Donors to Developing Countries: Key Issues and Recommendations for Policy and Research

This paper, published in the Journal of Global Health, explains why the transition of financing responsibility for health programs from external donors to domestic governments is picking up momentum; highlights the main challenges that countries and donors face in achieving smooth transitions that preserve health gains; points to the key strategies and tools that should be used in assessing, preparing, designing, and monitoring financial transitions; and finish by outlining a recommended agenda for priority research in this area.

Read more on the researchers’ strategies and tools for successful health program transitions here.

Leave a Reply

Your email address will not be published.

You May Also Like

COVAX Application Materials for AMC Eligible Economies Now Available

The COVAX Facility released the application and guidance documents (“application package”) for eligible economies to (i) confirm participation in the COVAX Facility and (ii) request support as part of COVAX. This comprises COVID-19 vaccines, as well as Cold Chain Equipment and Technical Assistance needed to prepare for the delivery of COVID-19 vaccines.  All 92 AMC Eligible … Continued

COVID-19: Gavi steps up response to pandemic

Gavi, the Vaccine Alliance, will provide US$ 29 million in urgent initial funding to 13 lower-income countries to support their response to COVID-19, helping them to protect health care workers with personal protective equipment (PPE), perform vital surveillance and training, and fund diagnostic tests. There are further requests or interest from 21 countries, meaning more … Continued

Center for Global Development – Global Immunization and Gavi: Five Priorities for the Next Five Years

Below is an excerpt from the Center for Global Development’s overview note.  Child vaccination remains among the most cost-effective uses of public and aid monies.[1] In a highly contested funding environment where priorities must be set for the allocation of scarce concessional resources, investment in expanding the availability and coverage of cost-effective vaccination must come … Continued